| Digit Symbol Substitution Test: The Case for Sensitivity Over Specificity in Neuropsychological Testing |
39 |
| Clozapine Metabolism in East Asians and Caucasians A Pilot Exploration of the Prevalence of Poor Metabolizers and a Systematic Review |
16 |
| The Potential for Pharmacokinetic Interactions Between Cannabis Products and Conventional Medications |
14 |
| Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial |
11 |
| Exploring the Prevalence of Clozapine Phenotypic Poor Metabolizers in 4 Asian Samples They Ranged Between 2% and 13% |
9 |
| Maintenance Ketamine Therapy for Treatment-Resistant Depression |
9 |
| The Effect of Body Weight Changes on Total Plasma Clozapine Concentrations Determined by Applying a Statistical Model to the Data From a Double-Blind Trial |
9 |
| Evaluating the Effect of Coenzyme Q10 Augmentation on Treatment of Bipolar Depression: A Double-Blind Controlled Clinical Trial |
9 |
| Is There a Potential of Misuse for Quetiapine? Literature Review and Analysis of the European Medicines Agency/European Medicines Agency Adverse Drug Reactions' Database |
8 |
| Personalized (N-of-1) Trials for Depression A Systematic Review |
8 |
| Efficacy and Safety of a Rapid Intravenous Injection of Ketamine 0.5 mg/kg in Treatment-Resistant Major Depression: An Open 4-Week Longitudinal Study |
8 |
| alpha 7 Nicotinic Acetylcholine Receptor A Potential Target in Treating Cognitive Decline in Schizophrenia |
7 |
| Exploring Nitrous Oxide as Treatment of Mood Disorders: Basic Concepts |
7 |
| Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users A Phase 1 Randomized Controlled Study |
6 |
| The Role of Atomoxetine for Parkinson Disease-Related Executive Dysfunction: A Systematic Review |
6 |
| Effects of Repeated Intravenous Ketamine in Treatment-Resistant Geriatric Depression A Case Series |
5 |
| A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder |
5 |
| Trends and Patterns of Antidepressant Use in French Children and Adolescents From 2009 to 2016 A Population-Based Study in the French Health Insurance Database |
5 |
| A Novel Text Message Intervention to Improve Adherence to Stimulants in Adults With Attention Deficit/Hyperactivity Disorder |
5 |
| Effect of Brexpiprazole on Prolactin An Analysis of Short- and Long-Term Studies in Schizophrenia |
5 |
| A Pilot, Randomized Clinical Trial of Bedtime Doses of Prazosin Versus Placebo in Suicidal Posttraumatic Stress Disorder Patients With Nightmares |
5 |
| Melancholic Symptoms in Bipolar II Depression and Responsiveness to Lamotrigine in an Exploratory Pilot Study |
4 |
| Maternal Antidepressant Use During Pregnancy and the Risk of Attention-Deficit/Hyperactivity Disorder in Children A Systematic Review of the Current Literature |
4 |
| Analysis of Clozapine Use and Safety by Using Comprehensive National Data From the Japanese Clozapine Patient Monitoring Service |
4 |
| Adjunct Aripiprazole Reduces Prolactin and Prolactin-Related Adverse Effects in Premenopausal Women With Psychosis Results From the DAAMSEL Clinical Trial |
4 |
| Case Reports of Aripiprazole and Problematic Gambling in Schizophrenia A Critical Review of the Evidence |
4 |
| Adverse Drug Reactions Related to Mood and Emotion in Pediatric Patients Treated for Attention Deficit/Hyperactivity Disorder A Comparative Analysis of the US Food and Drug Administration Adverse Event Reporting System Database |
4 |
| Age Impacts Olanzapine Exposure Differently During Use of Oral Versus Long-Acting Injectable Formulations: An Observational Study Including 288 Patients |
4 |
| An 8-Week, Randomized, Phase Double-Blind, Sequential Parallel-Group Comparison Study of Two Dose Levels of the GABAA Positive Allosteric Modulator PF-06372865 Compared With Placebo as an Adjunctive Treatment in Outpatients With Inadequate Response to Standard of Care for Generalized Anxiety Disorder |
4 |
| Comedication of Valproic Acid Is Associated With Increased Metabolism of Clozapine |
4 |
| Adjunctive Memantine Treatment of Schizophrenia A Double-Blind, Randomized Placebo-Controlled Study |
4 |
| Antipsychotic Use During Pregnancy and the Risk of Gestational Diabetes Mellitus A Systematic Review |
4 |
| Serotonin Toxicity Associated Agents and Clinical Characteristics |
3 |
| A Phase 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia |
3 |
| Methylenedioxymethamphetamine (MDMA) in Psychiatry: Pros, Cons, and Suggestions |
3 |
| Very Low-Dose Mirtazapine (7.5 mg) in Treatment of Acute Antipsychotic-Associated Akathisia |
3 |
| Intraindividual and Interindividual Variability of Olanzapine Trough Concentrations in Patients Treated With the Long-Acting Injectable Formulation |
3 |
| Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms A Pharmacoepidemiological Study |
3 |
| Sustained Impairment of Lurasidone Clearance After Discontinuation of Posaconazole Impact of Obesity, and Implications for Patient Safety |
3 |
| Is Antipsychotic Treatment Associated With Risk of Pneumonia in People With Serious Mental Illness? The Roles of Severity of Psychiatric Symptoms and Global Functioning |
3 |
| Hepatitis, Interstitial Nephritis, and Pancreatitis in Association With Clozapine Treatment: A Systematic Review of Case Series and Reports |
3 |
| Effect of Sertraline, Dosulepin, and Venlafaxine on Non-BDNF Neurotrophins in Patients With Depression A Cohort Study |
3 |
| Characteristics of Patients Experiencing Extrapyramidal Symptoms or Other Movement Disorders Related to Dopamine Receptor Blocking Agent Therapy |
3 |
| Lithium Carbonate in a Poststroke Population Exploratory Analyses of Neuroanatomical and Cognitive Outcomes |
2 |
| Effectiveness of Venlafaxine in Selective Serotonin Reuptake Inhibitor-Resistant Obsessive-Compulsive Disorder Experience From a Specialty Clinic in India |
2 |
| Estimating the Risk of Pneumonia in Patients With Schizophrenia Newly Receiving Clozapine A Nationwide Cohort Study |
2 |
| Model-Guided Antipsychotic Dose Reduction in Schizophrenia A Pilot, Single-Blind Randomized Controlled Trial |
2 |
| Prior Antidepressant Treatment Trials May Predict a Greater Risk of Depressive Relapse During Antidepressant Maintenance Therapy |
2 |
| Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia |
2 |
| Impact of Long-Term Lithium Treatment on Renal Function in Patients With Bipolar Disorder Based on Novel Biomarkers |
2 |
